Eurofins Scientific Investors Need More Than Profitability Improvement -- Market Talk
Dow Jones2026/09/29 07:120712 GMT - Eurofins Scientific's 2027 target of an improvement in profitability seems firmly within reach, but this is no longer enough as the debate among investors shifts back to growth, Bernstein analysts say in a research note. The French lab-testing company has historically delivered sustainable organic sales growth above 6%, but its growth engine now appears structurally weaker, the analysts say. Eurofins is heavily exposed to Europe, where clinical and research-and-development activity remains weak, and this might explain why organic growth in its biopharma business has remained subdued for the past two years, they add. Bernstein cuts its recommendation on Eurofins stock to market perform from outperform, and trims its target price to 73.90 euros from 77.20 euros. Shares fall 2.1% to 77.08 euros. (adria.calatayud@wsj.com)
(END) Dow Jones Newswires
September 29, 2026 03:12 ET (07:12 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moody’s gives Sky Protocol B3 rating as institutional interest in USDS grows

Brent crude oil falls to $104 per barrel, down 0.2% in 24 hours.

The relevant page of Hyperliquid Labs lists 5 OTC buyer wallet addresses.
BUZZ - Preview: Levi's shares decline, market focuses on high-end jeans sales
On Wednesday, October 7, Levi Strauss (LEVI.N) shares fell 4.3% to $19.65 ahead of the company's quarterly earnings release after the market close. With consumer spending becoming more cautious, investors are closely watching the company's progress in entering the premium jeans market. According to data from the London Stock Exchange Group (LSEG), the apparel manufacturer—known for its jeans and casual wear—is expected to report third-quarter revenue growth of about 5% year-on-year to $1.62 billion, with adjusted earnings per share at $0.36, higher than last year's $0.34. Last quarter, the company raised its annual sales forecast, betting that its premium jeans would attract high-income consumers, though its earnings outlook disappointed some investors. Jefferies, in a preview report, anticipated the third-quarter results would be "solid" given strong demand for jeans, and pointed out that the appointment of a new chief financial officer signals continued focus on future global growth. On September 30, Levi's announced the appointment of John Vandemore as chief financial officer, effective November 1, 2026; Vandemore previously worked at Skechers, where he served as corporate controller and led the global finance team for the past nine years. In response to this news, Levi's shares have declined about 5% year-to-date and approximately 20% over the past 12 months. Out of 16 brokerage firms, 13 rate the stock as "strong buy" or "buy," while 3 have it as "hold"; the median target price remains at $27, unchanged over the last three months.